Skip to main content

Advertisement

Table 3 Baseline RBP4 levels predicts the incidence and persistence of MS in the 10-year prospective study

From: Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study

  The incidence of MSa The persistence of MSb
OR/unit (95% CI) P OR/unit (95% CI) P
Model 1 1.77 (1.29–2.43) < 0.001 2.19 (1.14–4.20) 0.018
Model 2 1.68 (1.22–2.34) 0.002 2.32 (1.18–4.45) 0.015
Model 3 1.43 (1.01–2.04) 0.049 3.85 (1.51–9.84) 0.005
Model 4 1.66 (1.19–2.30) 0.003 2.28 (1.06–4.93) 0.036
  1. OR indicates odds ratio for per 10 μg/ml (approximately 1 SD) increase in baseline RBP4 levels
  2. BMI body mass index, TG triglycerides, HDL-C high-density lipoprotein cholesterol, MS metabolic syndrome
  3. a Excludes subjects with MS at baseline
  4. b Excludes subjects without MS at baseline
  5. Model 1: adjusted for age, gender, and pubertal stage at baseline
  6. Model 2: Model 1 + additionally adjusted with physical activity, dietary score and BMI at baseline
  7. Model 3: Model 1 + additionally adjusted with waist circumference, systolic blood pressure, HDL-C, fasting blood glucose and TG levels at baseline
  8. Model 4: Model 1 + additionally adjusted with adiponectin, leptin levels and BMI at baseline